Mode
Text Size
Log in / Sign up

Meta-analysis identifies DNA methylation markers linked to asthma exacerbations in diverse pediatric populationsBlood Markers May Predict Severe Asthma Attacks in Kids

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Meta-analysis identifies DNAm markers in diverse pediatric populations associated with asthma exacerbations.

This meta-analysis examines DNA methylation markers in African American and Latino pediatric populations and ethnically diverse participants to identify associations with asthma exacerbations. The study utilized extreme-phenotype comparisons between non-asthmatics and asthma exacerbators, analyzing whole-genome sequencing data from n=1,668 and RNA-seq data from n=1,209 participants. Additional samples included 1,192 pediatric populations, 1,516 ethnically diverse participants, and 393 nasal samples.

The analysis identified DNAm at 505 CpGs and 119 DMRs in whole blood associated with asthma exacerbations, with results identified at a significance level of p<9x10-8. Replication efforts confirmed 25 CpGs in blood cells, while cross-validation in nasal samples identified 7 CpGs. Furthermore, 42 cell-specific DNAm markers were detected, mainly driven by T cells, and 134 CpGs were associated with gene expression in whole blood.

Additional findings included 118 associations with T-cell receptor genes and 446 CpGs regulated by genetic variants. Methylation-predicted plasma proteins involved in host defense included 21 proteins, and one lung aging clock was associated with asthma exacerbations. The authors suggest these findings point to novel methylation biomarkers and candidate drugs for asthma, while acknowledging that safety data such as adverse events were not reported.

Asthma affects millions of children around the world. Sometimes, standard medicines do not stop a severe flare-up. Parents often feel helpless when their child struggles to breathe.

Current tools cannot always predict when an attack will happen. This uncertainty makes daily life stressful for families. We need better ways to see danger coming.

The surprising shift in science

Doctors usually treat symptoms after they start. This study looks for warning signs before the crisis. It changes how we think about asthma management.

We used to look only at genes. Now we look at epigenetics, which are like switches on the genes. These switches turn genes on or off.

Think of your DNA like a piano keyboard. Epigenetics are the fingers pressing the keys. They change how the music sounds without changing the notes.

In this case, chemical tags tell the immune system to act. These tags can change based on the environment. They help the body fight or heal.

What scientists actually tested

Researchers studied over 1,000 children from different backgrounds. They checked blood and nose samples for chemical changes. They compared kids with bad attacks to healthy kids.

The study included African American and Latino children. This is important because past research often missed these groups. Diversity helps us find better answers for everyone.

What this means for families

They spotted 505 specific chemical spots in the blood. These spots were linked to worse asthma attacks. The changes were found mostly in T cells.

T cells are like immune soldiers that fight infection. When they act up, it can cause trouble. This study shows exactly where they go wrong.

Important limitations to keep in mind

This doesn’t mean this treatment is available yet.

The study focused on children and specific groups. More work is needed to confirm these results. Science takes time to move from paper to practice.

Experts say this helps us understand the immune system better. It points to new ways to stop inflammation. But we are not ready to use this today.

The future path for this research

Scientists will run more trials to build better tools. One day, this could help prevent severe attacks. Doctors might use blood tests to check risk levels.

Approval takes years of safety checks and testing. Families should talk to their doctors about current care. Do not change medicines based on this news alone.

The future path for this research

Scientists will run more trials to build better tools. One day, this could help prevent severe attacks. Doctors might use blood tests to check risk levels.

Approval takes years of safety checks and testing. Families should talk to their doctors about current care. Do not change medicines based on this news alone.

Study Details

Study typeMeta analysis
Sample sizen = 1,668
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Background: Extreme-phenotype comparisons allowed the discovery of novel asthma genetic risk loci. However, this approach remains unexplored in epigenome-wide association studies (EWAS). We aimed to identify bulk and cell-specific methylation markers of asthma with severe exacerbations across diverse ancestry groups. Methods: We conducted a meta-EWAS of 739,543 CpGs in whole blood among 1,192 African American and Latino pediatric populations, comparing non-asthmatics and asthma exacerbators. Genome-wide CpGs were followed up for replication in a meta-analysis across 1,516 ethnically diverse participants and in a cross-tissue evaluation of 393 nasal samples. We conducted differentially methylated region (DMRs), cell-type-deconvoluted, and quantitative trait loci analyses (whole-genome sequencing n=1,668; RNA-seq n=1,209). We examined enrichment in traits, pathways, and druggable genes, and analyzed DNAm predictors of plasma proteins and aging. Results: DNAm at 505 CpGs and 119 DMRs in whole blood were associated with asthma exacerbations (p<9x10-8, {lambda}=1.05). We replicated 25 CpGs in blood cells, cross-validated 7 in nasal samples, and detected 42 cell-specific DNAm markers mainly driven by T cells. DNAm at 134 CpGs was associated with gene expression in whole blood, including 118 associations with T-cell receptor genes, and 446 CpGs were regulated by [&ge;]1 genetic variant. We found enrichment for previous associations with environmental exposures, immune disorders, immune and inflammatory pathways, and druggable genes by developmental drugs. 21 methylation-predicted plasma proteins, involved in host defense, and one lung aging clock were associated with asthma exacerbations. Conclusions: The first meta-EWAS of extreme asthma phenotypes identified hundreds of novel DNAm markers, suggesting novel methylation biomarkers and candidate drugs for asthma and supporting the role of T cells.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.